comparemela.com

Cecilia Jones News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agios Pharmaceuticals, Inc (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript February 15, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to the Agios Fourth Quarter 2023 Earnings Conference Call. At this time, all […]

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down After Earnings Miss

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […]

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down After Earnings Miss

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […]

Agios Pharmaceuticals, Inc (NASDAQ:AGIO) to Post Q3 2024 Earnings of ($1 48) Per Share, Leerink Partnrs Forecasts

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Leerink Partnrs issued their Q3 2024 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst A. Berens expects that the biopharmaceutical company will post earnings per share of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.